Accelerated Path to Cures

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Computers, Advanced Computing, Computer Science
Cover of the book Accelerated Path to Cures by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319732381
Publisher: Springer International Publishing Publication: April 25, 2018
Imprint: Springer Language: English
Author:
ISBN: 9783319732381
Publisher: Springer International Publishing
Publication: April 25, 2018
Imprint: Springer
Language: English

Accelerated Path to Cures provides a transformative perspective on the power of combining advanced computational technologies, modeling, bioinformatics and machine learning approaches with nonclinical and clinical experimentation to accelerate drug development. This book discusses the application of advanced modeling technologies, from target identification and validation to nonclinical studies in animals to Phase 1-3 human clinical trials and post-approval monitoring, as alternative models of drug development. As a case of successful integration of computational modeling and drug development, we discuss the development of oral small molecule therapeutics for inflammatory bowel disease, from the application of docking studies to screening new chemical entities to the development of next-generation in silico human clinical trials from large-scale clinical data. Additionally, this book illustrates how modeling techniques, machine learning, and informatics can be utilized effectively at each stage of drug development to advance the progress towards predictive, preventive, personalized, precision medicine, and thus provide a successful framework for Path to Cures. 

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Accelerated Path to Cures provides a transformative perspective on the power of combining advanced computational technologies, modeling, bioinformatics and machine learning approaches with nonclinical and clinical experimentation to accelerate drug development. This book discusses the application of advanced modeling technologies, from target identification and validation to nonclinical studies in animals to Phase 1-3 human clinical trials and post-approval monitoring, as alternative models of drug development. As a case of successful integration of computational modeling and drug development, we discuss the development of oral small molecule therapeutics for inflammatory bowel disease, from the application of docking studies to screening new chemical entities to the development of next-generation in silico human clinical trials from large-scale clinical data. Additionally, this book illustrates how modeling techniques, machine learning, and informatics can be utilized effectively at each stage of drug development to advance the progress towards predictive, preventive, personalized, precision medicine, and thus provide a successful framework for Path to Cures. 

More books from Springer International Publishing

Cover of the book Orthodox Christian Renewal Movements in Eastern Europe by
Cover of the book The Practice of Spatial Analysis by
Cover of the book Spectral Mapping Theorems by
Cover of the book Bleach Plant Effluents from the Pulp and Paper Industry by
Cover of the book Neutron Scattering and Other Nuclear Techniques for Hydrogen in Materials by
Cover of the book Entrepreneurship Centres by
Cover of the book Trust and Reputation Management Systems by
Cover of the book Himalayan Quality of Life by
Cover of the book Value Creation through Engineering Excellence by
Cover of the book Quantum Metrology, Imaging, and Communication by
Cover of the book Emotion, Affect and Personality in Speech by
Cover of the book Health Insurance by
Cover of the book Hot Carrier Degradation in Semiconductor Devices by
Cover of the book Geoecological Risk Management in Polar Areas by
Cover of the book Reachability Problems by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy